Intrinsic Value of S&P & Nasdaq Contact Us

Kintara Therapeutics, Inc. KTRA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
37/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Kintara Therapeutics, Inc. (KTRA) has 20 known insider and institutional holders on record. The largest holder is HOFFMAN ROBERT with 3,519,170 shares. Other notable holders include Liatos John and Praill Anthony Scott.

KTRA Insider Ownership

Top Holder
HOFFMAN ROBERT
3,519,170 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Hoffman Robert President and CEO 3,519,170 2021-11-10
100%
2 Liatos John SVP, Business Development 506,647 2020-09-17
14%
3 Praill Anthony Scott Chief Financial Officer 277,273 2022-08-03
8%
4 Yamashita Dennis Chief Scientific Officer 196,790 2024-10-22
6%
5 Seymour Tamara A Director 100,000 2022-07-05
3%
6 Murphy Keith Director 100,000 2021-09-22
3%
7 Ferrara Napoleone Director 75,000 2020-06-30
2%
8 Cranston Lynda Sarah Director 75,000 2020-06-30
2%
9 Bell John K Director 75,000 2020-06-30
2%
10 Bianco James A. Chief Executive Officer 71,560 2024-10-22
2%
11 Bacha Jeffrey Director 64,049 2018-04-03
2%
12 Praill Scott Chief Financial Officer 47,366 2017-10-05
1%
13 Hoffman Robert E. President, CEO and Interim CFO 23,142 2023-09-01
1%
14 Zarrabian Saiid Head of Strategic Partnerships 17,391 2021-12-08
0%
15 Garner William J Director 16,666 2015-07-17
0%
16 Dearborn Dan Chief Financial Officer 15,744 2024-10-22
0%
17 Ng George K Director 13,553 2024-10-22
0%
18 Manuso James S J Director 13,553 2024-10-22
0%
19 List Alan Director 13,553 2024-10-22
0%
20 Brown Dennis M Chief Scientific Officer 10,175 2023-09-01
0%

No ownership data available for KTRA.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message